Lung Cancer

Lung cancer screening adherence doesn’t match trial rates

In a major reality check for lung cancer screening advocates, adherence rates in the real world are a far cry from the achievements seen in RCTs such as the NELSON and NLST trials. A systematic review and meta-analysis of the evidence, comprising 19 US studies and almost 17,000 participants, has found an overall adherence rate ...

Already a member?

Login to keep reading.

© 2022 the limbic